InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-16.3%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Cohen Robert, Chief Executive Officer. Director active across 2 companies, notably Zomedica Corp.. In total, 6 reports have been recorded. History available since 1 June 2021. The latest transaction was disclosed on 3 January 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
4,362 shares0Common StockSEC:0001179110-22-000255:0
4,362 shares0Common StockSEC:0001179110-22-000255
543,750 shares@ US$0.2312.7% of flowCommon Stock, without par valueSEC:0001171843-21-004627
543,750 shares@ US$0.230.11% mcap12.7% of flowCommon Stock, without par valueSEC:0001171843-21-004627:0
2,000,000 shares@ US$0.1937.3% of flowCommon Stock, without par valueSEC:0001171843-21-003938
2,000,000 shares@ US$0.190.31% mcap37.3% of flowCommon Stock, without par valueSEC:0001171843-21-003938:0
6 of 6 declarations
About Cohen Robert
Robert Cohen is the Chief Executive Officer of Zomedica Corp. He is responsible for the strategic direction and management of the company's operations. His experience in the biotechnology sector is essential for guiding Zomedica towards innovation and growth.
